{"id":"https://openalex.org/W3081534359","doi":"https://doi.org/10.1158/1538-7755.disp19-b116","title":"Abstract B116: Evaluating the ability of clinically approved chemotherapeutics to decrease race-associated breast cancer mortality disparities via targeting the tumor-promoting effect of Crystallin Beta B2","display_name":"Abstract B116: Evaluating the ability of clinically approved chemotherapeutics to decrease race-associated breast cancer mortality disparities via targeting the tumor-promoting effect of Crystallin Beta B2","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3081534359","doi":"https://doi.org/10.1158/1538-7755.disp19-b116","mag":"3081534359"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7755.disp19-b116","doi":"https://doi.org/10.1158/1538-7755.disp19-b116","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7755.disp19-b116","pdf_url":null,"source":{"id":"https://openalex.org/S8391440","display_name":"Cancer Epidemiology Biomarkers & Prevention","issn_l":"1055-9965","issn":["1055-9965","1538-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Epidemiology, Biomarkers &amp; Prevention","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085451353","display_name":"Portia L. Andrews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Portia L. Andrews","raw_affiliation_strings":["North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088784123","display_name":"Denise K. Reaves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denise K. Reaves","raw_affiliation_strings":["North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104087883","display_name":"Megan E. Martin","orcid":"https://orcid.org/0000-0002-8837-508X","observed_orcids":["https://orcid.org/0000-0002-8837-508X"]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan E. Martin","raw_affiliation_strings":["North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055106514","display_name":"Michael Tarpley","orcid":"https://orcid.org/0009-0007-3712-7194","observed_orcids":["https://orcid.org/0009-0007-3712-7194"]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Tarpley","raw_affiliation_strings":["North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068362750","display_name":"Kevin P. Williams","orcid":"https://orcid.org/0000-0002-6930-4630","observed_orcids":["https://orcid.org/0000-0002-6930-4630"]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin P. Williams","raw_affiliation_strings":["North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050013847","display_name":"Jodie M. Fleming","orcid":"https://orcid.org/0000-0003-0297-5197","observed_orcids":["https://orcid.org/0000-0003-0297-5197"]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jodie M. Fleming","raw_affiliation_strings":["North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I123127086"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"6_Supplement_2","first_page":"B116","last_page":"B116"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13437","display_name":"Mechanisms of cancer metastasis","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crybb2","display_name":"CRYBB2","score":0.7770000100135803},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6809999942779541},{"id":"https://openalex.org/keywords/racial-disparities-in-cancer-mortality","display_name":"racial disparities in cancer mortality","score":0.7630000114440918},{"id":"https://openalex.org/keywords/african-american-women","display_name":"African American women","score":0.9869999885559082},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8700000047683716},{"id":"https://openalex.org/keywords/basal-like-breast-cancer","display_name":"basal-like breast cancer","score":0.9449999928474426},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.6330000162124634},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.7009999752044678},{"id":"https://openalex.org/keywords/tumor-promotion","display_name":"tumor promotion","score":0.375},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.6710000038146973},{"id":"https://openalex.org/keywords/cell-invasion","display_name":"cell invasion","score":0.8830000162124634},{"id":"https://openalex.org/keywords/3d-spheroid-culture","display_name":"3D spheroid culture","score":0.7770000100135803},{"id":"https://openalex.org/keywords/sum159-cells","display_name":"SUM159 cells","score":0.7120000123977661}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5779292583465576},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.551323413848877},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5414616465568542},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5325950980186462},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49851512908935547},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.46672454476356506},{"id":"https://openalex.org/C2780122803","wikidata":"https://www.wikidata.org/wiki/Q7852681","display_name":"Tumor promotion","level":4,"score":0.43617355823516846},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4353472590446472},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.433596134185791},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3801407814025879},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28553009033203125},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13738229870796204},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.08334994316101074}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7755.disp19-b116","doi":"https://doi.org/10.1158/1538-7755.disp19-b116","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7755.disp19-b116","pdf_url":null,"source":{"id":"https://openalex.org/S8391440","display_name":"Cancer Epidemiology Biomarkers & Prevention","issn_l":"1055-9965","issn":["1055-9965","1538-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Epidemiology, Biomarkers &amp; Prevention","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2972932997","https://openalex.org/W4313891545","https://openalex.org/W2887882975","https://openalex.org/W2298084928","https://openalex.org/W3192369490","https://openalex.org/W6977277068","https://openalex.org/W2565687771","https://openalex.org/W6921411300","https://openalex.org/W4406636374","https://openalex.org/W6902245267"],"abstract_inverted_index":{"Abstract":[0],"In":[1,146],"the":[2,9,22,72,129,152,237,262,265,322,325,347,384,418,453,468,479,484,494],"United":[3],"States,":[4],"breast":[5,98,161,462],"cancer":[6,14,162,463],"(BC)":[7],"remains":[8],"second":[10],"leading":[11],"cause":[12],"of":[13,24,61,101,132,148,155,223,248,264,294,324,332,351,387,405,455,471,478,486],"death":[15],"in":[16,21,26,96,109,157,185,317,336,357,364,370,395,417,490],"women.":[17],"The":[18,403],"unequal":[19],"burden":[20],"mortality":[23,53,464],"BC":[25,65,143,271,396],"African":[27],"American":[28,34],"(AA)":[29],"women":[30,36],"compared":[31,192],"to":[32,57,63,70,106,193,245,260,278,291,301,382,420,459],"Caucasian":[33],"(CA)":[35],"goes":[37],"without":[38],"full":[39],"explanation.":[40],"When":[41],"socioeconomic":[42],"factors":[43],"such":[44],"as":[45],"education":[46],"and":[47,75,113,118,121,173,183,205,236,274,330,362,374,427,493],"income":[48],"are":[49,431],"accounted":[50],"for,":[51],"this":[52,79],"disparity":[54],"persists.":[55],"Therefore,":[56],"acquire":[58],"an":[59],"understanding":[60],"how":[62],"end":[64],"disparities,":[66],"it":[67],"is":[68,139],"crucial":[69],"examine":[71],"underlying":[73],"cellular":[74],"molecular":[76],"mechanisms":[77,131,197],"driving":[78],"disproportionate":[80],"outcome.":[81,209],"Studies":[82],"on":[83,327,483],"gene":[84],"expression":[85,95,135,167,285],"analyses":[86],"have":[87],"identified":[88,297],"a":[89],"particular":[90,292],"gene,":[91],"CRY\u03b2B2,":[92,219,231],"with":[93,125,142,188,232,241,282,298,312,339,366,398],"higher":[94],"AA":[97,112],"tumors.":[99],"Expression":[100],"CRY\u03b2B2":[102,134,156,166,191,225,233,243,284,304,314,411],"was":[103,168,258],"also":[104],"found":[105],"be":[107,355,380,415],"increased":[108,299],"studies":[110,320,359],"comparing":[111],"CA":[114],"colorectal,":[115],"renal,":[116],"glioblastoma,":[117],"prostate":[119],"cancers,":[120],"has":[122],"been":[123],"linked":[124],"decreased":[126],"survival.":[127],"Although":[128],"precise":[130],"elevated":[133],"remain":[136],"unknown,":[137],"overexpression":[138,175],"significantly":[140,345],"associated":[141],"tumor":[144,203],"promotion.":[145],"view":[147],"this,":[149],"we":[150,220],"investigated":[151],"biological":[153],"effects":[154,263],"basal-like,":[158],"triple":[159],"negative":[160],"(TNBC)":[163],"cell":[164,256,272,341],"lines.":[165],"manipulated":[169],"via":[170,369,466],"CRIPSR/Cas9-mediated":[171],"knockout":[172],"lentiviral":[174],"systems.":[176],"Our":[177],"preliminary":[178],"data":[179],"show":[180],"enhanced":[181],"proliferation":[182,348],"invasion":[184,331,350],"3D":[186,269,337],"cultures":[187,338],"cells":[189,217,229,240,281,302,353],"overexpressing":[190,218,230,303],"controls,":[194],"suggesting":[195],"two":[196,308],"by":[198,267],"which":[199],"CRY\u03b2B2-overexpression":[200],"may":[201,214,413],"enhance":[202],"promotion":[204],"promote":[206],"poor":[207],"patient":[208],"To":[210],"identify":[211],"drugs":[212,266,326,408],"that":[213,344,400,409],"specifically":[215],"target":[216],"subjected":[221],"one":[222],"our":[224],"model":[226],"systems":[227],"(SUM159":[228],"knocked":[234],"out,":[235],"parental":[238],"SUM159":[239],"low":[242],"expression)":[244],"increasing":[246],"doses":[247],"125":[249],"clinically":[250,406,456],"approved":[251,407,457],"chemotherapeutics.":[252],"High":[253],"content":[254],"live":[255,340],"imaging":[257],"used":[259,381],"evaluate":[261],"measuring":[268],"spheroid":[270],"growth,":[273],"IC50":[275],"were":[276,286,305,334],"generated":[277],"determine":[279],"whether":[280],"altered":[283,313],"more":[287,425],"or":[288,349,392],"less":[289,428],"sensitive":[290],"classes":[293],"drugs.":[295],"Drugs":[296,343],"cytotoxicity":[300,329],"confirmed":[306],"using":[307],"additional":[309],"TNBC":[310],"models":[311],"levels.":[315],"Additional":[316],"vitro":[318],"mechanistic":[319],"evaluating":[321],"effect":[323,470],"proliferation,":[328],"CRY\u03b2B2-overexpressing":[333,352],"executed":[335],"imaging.":[342],"affect":[346],"will":[354,379],"evaluated":[356],"future":[358],"for":[360,390],"efficacy":[361],"toxicity":[363],"conjunction":[365],"other":[367],"chemotherapeutics":[368,389,458],"vivo":[371],"AA-specific":[372],"xenografts":[373],"PDX":[375],"models.":[376],"This":[377],"information":[378],"explore":[383],"potential":[385],"use":[386],"these":[388],"neoadjuvant":[391],"adjuvant":[393],"therapy":[394],"patients":[397],"tumors":[399],"overexpress":[401],"CRY\u03b2B2.":[402],"identification":[404],"inhibit":[410],"function":[412],"quickly":[414],"applied":[416],"clinic":[419],"increase":[421],"survival":[422],"rates":[423],"until":[424],"effective":[426],"toxic,":[429],"targeted-therapies":[430],"developed.":[432],"Citation":[433],"Format:":[434],"Portia":[435],"L.":[436],"Andrews,":[437],"Denise":[438],"K.":[439],"Reaves,":[440],"Megan":[441],"E.":[442],"Martin,":[443],"Michael":[444],"Tarpley,":[445],"Kevin":[446],"P.":[447],"Williams,":[448],"Jodie":[449],"M.":[450],"Fleming.":[451],"Evaluating":[452],"ability":[454],"decrease":[460],"race-associated":[461],"disparities":[465],"targeting":[467],"tumor-promoting":[469],"Crystallin":[472],"Beta":[473],"B2":[474],"[abstract].":[475],"In:":[476],"Proceedings":[477],"Twelfth":[480],"AACR":[481],"Conference":[482],"Science":[485],"Cancer":[487,506],"Health":[488],"Disparities":[489],"Racial/Ethnic":[491],"Minorities":[492],"Medically":[495],"Underserved;":[496],"2019":[497],"Sep":[498],"20-23;":[499],"San":[500],"Francisco,":[501],"CA.":[502],"Philadelphia":[503],"(PA):":[504],"AACR;":[505],"Epidemiol":[507],"Biomarkers":[508],"Prev":[509],"2020;29(6":[510],"Suppl_2):Abstract":[511],"nr":[512],"B116.":[513]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2020-09-08T00:00:00"}
